BioPharma Services has been awarded a 5 year, $20 million contract with the Center for Drug Evaluation and Research (CDER), a division of the US FDA.

BioPharma Services Inc. is proud to announce that its Toronto-based Bioanalytical laboratory has successfully passed inspection by the Brazilian ANVISA.

The Standards Council of Canada has granted BioPharma Services recognition to the OECD’s Principles of Good Laboratory Practices (GLP).

BioPharma’s Toronto facility for Phase I/IIa clinical trials, bioequivalence studies has been successfully audited by US Food and Drug Administration (FDA).

BioPharma Services, a full service clinical research organization, announces the grand opening of its new Phase 1 Clinical Trial Facility in Columbia, Missouri.